NLRP3 and liver mesenchymal hamartoma: Interleukin-37 (IL-37), a member of the IL-1 cytokine family, has been demonstrated to alleviate CVB3-induced VMC in mice by suppressing the NF-κB pathway activation and inhibiting the NLRP3 inflammasome activity (Sun et al., 2022).